Answer questions and earn CME/CNE Thyroid cancer exists in several forms. Differentiated
thyroid cancers include those with papillary and follicular histologies. These tumors exist …

Hürthle cell carcinoma (HCC) can present either as a minimally invasive or as a widely
invasive tumor. HCC generally has a more aggressive clinical behavior compared with the …

Background Whether a threshold nodule size should prompt diagnostic thyroidectomy
remains controversial. We examined a consecutive series of patients who all had …

Hürthle cell carcinoma (HCC) is a distinct type of thyroid cancer genetically characterized by
DNA copy number alterations (CNA), typically of genome haploidization type (GH-type) …

Background Rates of thyroid cancer in patients with multinodular goitre (MNG) vary widely,
from 3 per cent in older studies to 35 per cent in more recent studies. The purpose of the …

Abstract Somatostatin receptor type 2 (SSTR2) and thyroid-stimulating hormone receptor
(TSHR) display variable expression in primary thyroid tumors and have been implicated as …

Abstract Learning Objectives After completing this course, the reader will be able to:
Enumerate the variable thyroid pathological conditions in which Hürthle cells are seen and …

Introduction Hürthle cell carcinoma (HCC) comprises about 5% of thyroid carcinoma cases.
Partly because of its rarity there is much we still need to know about HCC as compared to …

Background: Hürthle cell/oncocytic change is commonly reported on thyroid fine-needle
aspiration (FNA) and may be considered an “atypical cell” by clinicians. This study aims to …

Background The association of tumor size with malignancy in thyroid nodules with
indeterminate cytology (atypia of undetermined significance [AUS]/follicular lesion of …